Council of State Bioscience Associations Announces New Board Leadership
WASHINGTON, DC (October 3, 2011) – The Biotechnology Industry Organization (BIO) today announced the Council of State Bioscience Associations(CSBA) has selected its Executive Committee and Board of Directors for the 2011-2012 term. The CSBA is an autonomous council of state-based biotechnology associations operating within BIO.
"We are very pleased to have these distinguished state trade association leaders from across the nation working with BIO on vital economic development and regulatory matters facing our industry," said Peter Pellerito, Interim Vice President of State Government Relations and Alliance Development at BIO. "The CSBA has provided over fifteen years of invaluable support to universities, policymakers and industry, enabling a consistent voice for life science policy in state capitols. We look forward to continued insight and collaboration as we keep our industry vibrant and competitive in an increasingly global economy."
Members of the CSBA Executive Committee and Board of Directors for the 2011-2012 term are:
Chris Rivera, CSBA Board Chair, Executive Committee
President, Washington Biotechnology & Biomedical Association
Robert Dayton CSBA Vice Chair, Executive Committee
President, Delaware BioScience Association
Kelly Gillespie, Past Chair, Executive Committee
Executive Director, Missouri Biotechnology Association
Liz Larkin, Board Member
Executive Director, South Dakota Biotech Association
Gail Maderis, Board Member
President and Chief Executive Officer, BayBio
Russell Allen, Board Member
President & CEO, BioFlorida
Nathan Tinker, Board Member
Executive Director, New York Biotechnology Association
Tom Kowalski, Board Member
President of the Texas Healthcare and Bioscience Institute
Richard Nelson, Board Member
President and CEO, Utah Technology Council
The CSBA is a confederation of 48 state-based, non-profit trade organizations, each governed by its own board of directors. The mission of the CSBA is to promote public understanding, and to advocate for public policies that support the responsible development of the bioscience industry. These groups are recognized by BIO as affiliate organizations in their respective states.